The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants

被引:172
作者
Hagopian, William A. [1 ]
Erlich, Henry [2 ]
Lernmark, Ake [3 ]
Rewers, Marian [4 ]
Ziegler, Anette G. [5 ]
Simell, Olli
Akolkar, Beena [7 ]
Vogt, Robert, Jr. [8 ]
Blair, Alan [2 ]
Ilonen, Jorma [6 ,9 ]
Krischer, Jeffrey [10 ]
She, JinXiong [11 ]
机构
[1] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA
[2] Roche Mol Syst, Pleasanton, CA USA
[3] Lund Univ, Univ Hosp UMAS, Dept Clin Sci, Malmo, Skane, Sweden
[4] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA
[5] Tech Univ Munich, Diabet Res Inst, Munich, Germany
[6] Univ Turku, Dept Pediat, Immunogenet Lab, Turku, Finland
[7] NIDDK, DDEMD, Bethesda, MD USA
[8] Ctr Dis Control & Prevent, Newborn Screening Branch, Div Sci Lab, Atlanta, GA USA
[9] Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland
[10] Univ S Florida, Pediat Epidemiol Ctr, Dept Informat & Biostat, Tampa, FL USA
[11] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA
关键词
autoimmunity; genetic screening; population based; prediction; T1D; GENOME-WIDE ASSOCIATION; HLA-DR; TYPE-1; POPULATION; SUSCEPTIBILITY; IDDM; DQ; AUTOIMMUNITY; HAPLOTYPES; GENOTYPES;
D O I
10.1111/j.1399-5448.2011.00774.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The Environmental Determinants of Diabetes in the Young (TEDDY) study seeks to identify environmental factors influencing the development of type 1 diabetes (T1D) using intensive follow-up of children at elevated genetic risk. This study requires a cost-effective yet accurate screening strategy to identify the high-risk cohort. Methods: The TEDDY cohort was identified through newborn screening using human leukocyte antigen (HLA) class II genes based on criteria established with pre-TEDDY data. HLA typing was completed at six international centers using different genotyping methods that can achieve >98% accuracy. Results: TEDDY developed separate inclusion criteria for the general population (GP) and first-degree relatives (FDRs) of T1D patients. The FDR eligibility includes nine haplogenotypes (DR3/4, DR4/4, DR4/8, DR3/3, DR4/4b, DR4/1, DR4/13, DR4/9, and DR3/9) for broad HLA diversity, whereas the GP eligibility includes only the first four haplogenotypes with DRB1*0403 as an exclusion allele. TEDDY has screened 414 714 GP infants, of which 19 906 (4.8%) were eligible, whereas 1415 of the 6333 screened FDR infants (22.2%) were eligible. High-resolution confirmation testing of the eligible subjects indicated that the low-cost and low-resolution genotyping techniques employed at the screening centers yielded an accuracy of 99%. There were considerable variations in eligibility rates among the centers for GP (3.5-7.4%) and FDR (19-32%) subjects. The eligibility rates among US ethnic groups were 0.9, 1.3, 5.0, and 6.9% for Asians, Black, Caucasians, and Hispanics, respectively. Conclusions: Different low-cost and low-resolution genotyping methods are useful for the efficient and accurate identification of a high-risk cohort for follow-up based on the TEDDY HLA inclusion criteria (ClinicalTrials.gov NCT00279318).
引用
收藏
页码:733 / 743
页数:11
相关论文
共 28 条
[1]   Human genetic variation studies and HLA class II loci [J].
Agrawal, S. ;
Khan, F. ;
Bharadwaj, U. .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (04) :247-252
[2]  
Akerblorn Hans K., 2007, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V7, P251
[3]   Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes [J].
Barrett, Jeffrey C. ;
Clayton, David G. ;
Concannon, Patrick ;
Akolkar, Beena ;
Cooper, Jason D. ;
Erlich, Henry A. ;
Julier, Cecile ;
Morahan, Grant ;
Nerup, Jorn ;
Nierras, Concepcion ;
Plagnol, Vincent ;
Pociot, Flemming ;
Schuilenburg, Helen ;
Smyth, Deborah J. ;
Stevens, Helen ;
Todd, John A. ;
Walker, Neil M. ;
Rich, Stephen S. .
NATURE GENETICS, 2009, 41 (06) :703-707
[4]   IDDMI and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes [J].
Bonifacio, E ;
Hummel, M ;
Walter, M ;
Schmid, S ;
Ziegler, AG .
DIABETES CARE, 2004, 27 (11) :2695-2700
[5]   Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls [J].
Burton, Paul R. ;
Clayton, David G. ;
Cardon, Lon R. ;
Craddock, Nick ;
Deloukas, Panos ;
Duncanson, Audrey ;
Kwiatkowski, Dominic P. ;
McCarthy, Mark I. ;
Ouwehand, Willem H. ;
Samani, Nilesh J. ;
Todd, John A. ;
Donnelly, Peter ;
Barrett, Jeffrey C. ;
Davison, Dan ;
Easton, Doug ;
Evans, David ;
Leung, Hin-Tak ;
Marchini, Jonathan L. ;
Morris, Andrew P. ;
Spencer, Chris C. A. ;
Tobin, Martin D. ;
Attwood, Antony P. ;
Boorman, James P. ;
Cant, Barbara ;
Everson, Ursula ;
Hussey, Judith M. ;
Jolley, Jennifer D. ;
Knight, Alexandra S. ;
Koch, Kerstin ;
Meech, Elizabeth ;
Nutland, Sarah ;
Prowse, Christopher V. ;
Stevens, Helen E. ;
Taylor, Niall C. ;
Walters, Graham R. ;
Walker, Neil M. ;
Watkins, Nicholas A. ;
Winzer, Thilo ;
Jones, Richard W. ;
McArdle, Wendy L. ;
Ring, Susan M. ;
Strachan, David P. ;
Pembrey, Marcus ;
Breen, Gerome ;
St Clair, David ;
Caesar, Sian ;
Gordon-Smith, Katherine ;
Jones, Lisa ;
Fraser, Christine ;
Green, Elain K. .
NATURE, 2007, 447 (7145) :661-678
[6]   Prospective assessment in newborns of diabetes autoimmunity (PANDA): Maternal understanding of infant diabetes risk [J].
Carmichael, SK ;
Johnson, SB ;
Baughcum, A ;
North, K ;
Hopkins, D ;
Dukes, MG ;
She, JX ;
Schatz, DA .
GENETICS IN MEDICINE, 2003, 5 (02) :77-83
[7]   Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates [J].
Emery, LM ;
Babu, S ;
Bugawan, TL ;
Norris, JM ;
Erlich, HA ;
Eisenbarth, GS ;
Rewers, M .
PEDIATRIC DIABETES, 2005, 6 (03) :136-144
[8]   HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families [J].
Erlich, Henry ;
Valdes, Ana Maria ;
Noble, Janelle ;
Carlson, Joyce A. ;
Varney, Mike ;
Concannon, Pat ;
Mychaleckyj, Josyf C. ;
Todd, John A. ;
Bonella, Persia ;
Fear, Anna Lisa ;
Lavant, Eva ;
Louey, Anthony ;
Moonsamy, Priscilla .
DIABETES, 2008, 57 (04) :1084-1092
[9]   A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene [J].
Hakonarson, Hakon ;
Grant, Struan F. A. ;
Bradfield, Jonathan P. ;
Marchand, Luc ;
Kim, Cecilia E. ;
Glessner, Joseph T. ;
Grabs, Rosemarie ;
Casalunovo, Tracy ;
Taback, Shayne P. ;
Frackelton, Edward C. ;
Lawson, Margaret L. ;
Robinson, Luke J. ;
Skraban, Robert ;
Lu, Yang ;
Chiavacci, Rosetta M. ;
Stanley, Charles A. ;
Kirsch, Susan E. ;
Rappaport, Eric F. ;
Orange, Jordan S. ;
Monos, Dimitri S. ;
Devoto, Marcella ;
Qu, Hui-Qi ;
Polychronakos, Constantin .
NATURE, 2007, 448 (7153) :591-U7
[10]   HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland:: An analysis of 622 nuclear families [J].
Hermann, R ;
Turpeinen, H ;
Laine, AP ;
Veijola, R ;
Knip, M ;
Simell, O ;
Sipilä, I ;
Åkerblom, HK ;
Ilonen, J .
TISSUE ANTIGENS, 2003, 62 (02) :162-169